1. Market Research
  2. > Pathology
22 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: Non-Hodgkin Lymphoma Forecast in 18 Major Markets 2017-2027

  • $ 4740
  • February 2017
  • 92 pages

Mantle Cell Lymphoma patients by Ann Arbour Stage, (##s) Italy Mexico BURKITT' S LYMPHOMA Table ##.

  • Cancer
  • Lymphoma
  • Pathology
  • North America
  • Forecast

Epiomic Epidemiology Series: PD-L1 Overexpression in Solid Tumours Forecast in 18 Major Markets 2017-2027

  • $ 5557
  • June 2017
  • 148 pages

Distribution of lymphomas in Poland according to World Health Organisation classification: analysis of ## cases from National Histopathological Lymphoma Register project - the Polish Lymphoma Research Group study.

  • Cancer
  • Colorectal Cancer
  • Lymphoma
  • Pathology
  • North America

EPIOMIC EPIDEMIOLOGY SERIES: RETINAL DETACHMENT FORECAST IN 18 MAJOR MARKETS 2018–2028

  • $ 5577
  • February 2018
  • 58 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Retinal Detachment in 18 Major Markets Retinal detachment (RD) is a condition in which the neurosensory retina (NSR), a layer of the retina ...

  • Eye Disease
  • Healthcare
  • Pathology

EPIOMIC EPIDEMIOLOGY SERIES: ADDISON’S DISEASE FORECAST IN 22 MAJOR MARKETS 2018–2028

  • $ 5577
  • September 2018
  • 70 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Addison’s Disease in 22 Major Markets Addison’s disease (AD) is a chronic and rare endocrinal disorder, caused by destruction of the ...

  • Pathology

EPIOMIC EPIDEMIOLOGY SERIES: UVEITIS FORECAST IN 18 MAJOR MARKETS 2018–2028

  • $ 5577
  • February 2018
  • 84 pages

The third option is the so-called masquerade uveitis whose cause is not of inflammatory nature-usually a neoplasm (most often lymphoma).

  • Pathology

EPIOMIC EPIDEMIOLOGY SERIES: MYELOPROLIFERATIVE NEOPLASMS FORECAST IN 12 MAJOR MARKETS 2017–2027

  • $ 6538
  • November 2017
  • 39 pages

Leukaemia Lymphoma. 1991; ##(##):##-## ##.

  • Lymphoma
  • Pathology
  • East Asia
  • Southern Europe
  • Western Europe

Epiomic Epidemiology Series: Hodgkin’s Lymphoma Forecast in 17 Major Markets 2016-2026

  • $ 4741
  • October 2016
  • 60 pages

The inclusion of Reed Sternberg cells, a type of white blood cell called a B lymphocyte, helps clinicians to delineate HL from other types of lymphoma.

  • Cancer
  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Haemophagocytic lymphohistiocytosis (HLH) Forecast in 14 Major Markets 2016-2026

  • $ 4087
  • October 2016
  • 52 pages

Autoimmune conditions Leukaemia Lymphomas HSCT Infection (especially with EBV) Diabetes Obesity COPD Heart Failure EPIOMIC EPIDEMIOLOGY SERIES: HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FORECAST IN ## MAJOR MARKETS 2016-2026 TOP-LINE INCIDENCE FOR HLH The following tables state the projected inci

  • Health Services
  • Lymphoma
  • Northern Europe

Epiomic Epidemiology Series: Leukaemia Forecast in 18 Major Markets 2017-2027

  • $ 4741
  • January 2017
  • 82 pages

For example, Burkitt' s lymphoma is closely associated with Epstein Barr virus (EBV).

  • Cancer
  • Leukemia
  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 12 Major Markets 2017-2027

  • $ 4087
  • February 2017
  • 60 pages

Risk of lymphoma associated with combination anti-tumour necrosis factor and immunomodulator therapy for the treatment of Crohn' s disease: a meta-analysis.

  • Autoimmune Disease
  • Healthcare
  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Cachexia Forecast in 8 Major Markets 2016-2026

  • $ 5557
  • August 2016
  • 46 pages

Breast Haem GUI H & N Skin *Dig = Digestive, includes: Colorectal, oesophageal, gastric, gallbladder, liver & pancreatic; Haem = Haematological, includes: Leukaemias, lymphomas & multiple myeloma; GUI = Genitourinary, includes: kidney, bladder, prostate, testicular, ovarian, ute

  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Autoimmune Haemolytic Anemia Forecast in 8 Major Markets 2016-2026

  • $ 4087
  • July 2016
  • 48 pages

Leuk Lymphoma. 2009; ##(##):##-##.

  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Crohn’s Disease Forecast in 12 Major Markets 2017-2027

  • $ 4087
  • January 2017
  • 68 pages

Risk of lymphoma associated with combination anti-tumour necrosis factor and immunomodulator therapy for the treatment of Crohn' s disease: a meta-analysis.

  • Digestive System Disorder
  • Healthcare
  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Polycythemia Vera Forecast in 27 Major Markets 2016-2026

  • $ 4741
  • December 2016
  • 102 pages

Leuk Lymphoma, 1991, ##(##):##-## ##.

  • Blood Disease
  • Lymphoma
  • Pathology
  • Northern Europe
  • Western Europe

Market Report for PET Imaging in the USA

  • $ 5557
  • May 2016
  • 139 pages

USA PET scans 2010-2015 Within the USA the majority of PET scans are used in patients with lung cancer, breast cancer and lymphoma, which account for nearly ##% of all oncology scans (Figure ##) Figure ##.

  • CT Scan
  • Diagnostic Imaging
  • Lymphoma
  • North America
  • United States

Market Report for PET Imaging in Top 5 EU Markets

  • $ 5557
  • May 2016
  • 157 pages

LYMPHOMA AND LUNG CANCER PATIENTS MAKE UP THE BULK OF THE ONCOLOGY PROCEDURES WITH OTHER CANCERS MAKING UP THE REMAINING ##%.

  • Diagnostic Imaging
  • Healthcare
  • Hospital
  • Lymphoma
  • Nuclear Imaging Equipment

Market Report for PET Imaging in Japan

  • $ 5557
  • May 2016
  • 72 pages

Diseases covered for screening Lung cancer Breast cancer Colorectal cancer Pancreatic cancer Metastatic liver tumor Head and neck cancer Malignant lymphoma Malignant melanoma Brain tumor Origin unknown malignant tumor Table ##.

  • CT Scan
  • Lymphoma
  • East Asia
  • Japan
  • Shimadzu Corporation

Epiomic Epidemiology Series: Essential Thrombocythemia Forecast in 9 Major Markets 2016-2026

  • $ 4087
  • April 2016
  • 40 pages

Leukaemia Lymphoma. 1991; ##(##):##-## ##.

  • Blood Disease
  • Blood Supply
  • Healthcare
  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

  • $ 5064
  • February 2016
  • 42 pages

Risk of lymphoma associated with combination anti-tumour necrosis factor and immunomodulator therapy for the treatment of Crohn' s disease: a meta-analysis.

  • Autoimmune Disease
  • Healthcare
  • Lymphoma
  • Pathology

Epiomic Epidemiology Series: Crohn’s Disease Forecast in 8 Major Markets 2016-2026

  • $ 5064
  • January 2016
  • 48 pages

Risk of lymphoma associated with combination anti-tumour necrosis factor and immunomodulator therapy for the treatment of Crohn' s disease: a meta-analysis.

  • Digestive System Disorder
  • Healthcare
  • Lymphoma
  • Pathology
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on